DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 226 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $4,245,000 | -18.1% | 1,187,491 | -8.6% | 0.00% | 0.0% |
| Q2 2019 | $5,186,000 | -38.9% | 1,299,711 | +11.9% | 0.00% | -42.9% |
| Q1 2019 | $8,489,000 | -17.4% | 1,161,338 | +3.4% | 0.01% | -30.0% |
| Q4 2018 | $10,275,000 | -8.3% | 1,122,938 | +24.2% | 0.01% | 0.0% |
| Q3 2018 | $11,211,000 | +1121000.0% | 904,133 | +1189548.7% | 0.01% | – |
| Q2 2018 | $1,000 | 0.0% | 76 | +15.2% | 0.00% | – |
| Q1 2018 | $1,000 | 0.0% | 66 | +15.8% | 0.00% | – |
| Q4 2017 | $1,000 | – | 57 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chicago Capital, LLC | 5,791,735 | $85,543,929 | 4.00% |
| Deep Track Capital, LP | 6,756,956 | $99,800,240 | 3.85% |
| Intrinsic Edge Capital Management LLC | 1,133,099 | $16,735,872 | 1.89% |
| Bain Capital Life Sciences Investors, LLC | 915,000 | $13,514,550 | 1.51% |
| Kynam Capital Management, LP | 500,000 | $7,385,000 | 1.21% |
| Rhenman & Partners Asset Management AB | 700,000 | $10,339,000 | 1.12% |
| AlphaCentric Advisors LLC | 110,000 | $1,624,700 | 0.92% |
| HighVista Strategies LLC | 133,000 | $1,964,410 | 0.91% |
| Affinity Asset Advisors, LLC | 200,000 | $2,954,000 | 0.83% |
| Rock Springs Capital Management LP | 1,813,758 | $26,789,206 | 0.72% |